 | • レポートコード：QYR9ST04524 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、永続的な顔面紅斑の治療の世界市場について調査・分析し、永続的な顔面紅斑の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害剤）、用途別（病院、外来手術センター、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の永続的な顔面紅斑の治療市場動向 ・主要企業別マーケットシェア ・永続的な顔面紅斑の治療の種類別市場規模2014-2019 （皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害剤） ・永続的な顔面紅斑の治療の用途別市場規模2014-2019 （病院、外来手術センター、クリニック、その他） ・永続的な顔面紅斑の治療の北米市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療の中国市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療のインド市場：主要企業・種類別/用途別市場規模 ・永続的な顔面紅斑の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Anacor Pharmaceuticals、Astellas Pharma、Galderma、Meda Pharmaceuticals、Novartis、Pfizer、Regeneron Pharmaceuticals、Sanofi、Valeant Pharmaceuticals） ・永続的な顔面紅斑の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Facial erythema is a very common reason for consulting a dermatologist.While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases.
In 2018, the global Persistent Facial Erythema Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Persistent Facial Erythema Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Persistent Facial Erythema Treatment development in United States, Europe and China.
The key players covered in this study
Anacor Pharmaceuticals
Astellas Pharma
Galderma
Meda Pharmaceuticals
Novartis
Pfizer
Regeneron Pharmaceuticals
Sanofi
Valeant Pharmaceuticals
Market segment by Type, the product can be split into
Emollients
Antihistamines
Antifungal
Antibiotics
Corticosteroids
Calcineurin Inhibitors
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Persistent Facial Erythema Treatment status, future forecast, growth opportunity, key market and key players.
To present the Persistent Facial Erythema Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Persistent Facial Erythema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Emollients
1.4.3 Antihistamines
1.4.4 Antifungal
1.4.5 Antibiotics
1.4.6 Corticosteroids
1.4.7 Calcineurin Inhibitors
1.5 Market by Application
1.5.1 Global Persistent Facial Erythema Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Persistent Facial Erythema Treatment Market Size
2.2 Persistent Facial Erythema Treatment Growth Trends by Regions
2.2.1 Persistent Facial Erythema Treatment Market Size by Regions (2014-2025)
2.2.2 Persistent Facial Erythema Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Persistent Facial Erythema Treatment Market Size by Manufacturers
3.1.1 Global Persistent Facial Erythema Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Persistent Facial Erythema Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Persistent Facial Erythema Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Persistent Facial Erythema Treatment Key Players Head office and Area Served
3.3 Key Players Persistent Facial Erythema Treatment Product/Solution/Service
3.4 Date of Enter into Persistent Facial Erythema Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Persistent Facial Erythema Treatment Market Size by Type (2014-2019)
4.2 Global Persistent Facial Erythema Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Persistent Facial Erythema Treatment Market Size (2014-2019)
5.2 Persistent Facial Erythema Treatment Key Players in United States
5.3 United States Persistent Facial Erythema Treatment Market Size by Type
5.4 United States Persistent Facial Erythema Treatment Market Size by Application
6 Europe
6.1 Europe Persistent Facial Erythema Treatment Market Size (2014-2019)
6.2 Persistent Facial Erythema Treatment Key Players in Europe
6.3 Europe Persistent Facial Erythema Treatment Market Size by Type
6.4 Europe Persistent Facial Erythema Treatment Market Size by Application
7 China
7.1 China Persistent Facial Erythema Treatment Market Size (2014-2019)
7.2 Persistent Facial Erythema Treatment Key Players in China
7.3 China Persistent Facial Erythema Treatment Market Size by Type
7.4 China Persistent Facial Erythema Treatment Market Size by Application
8 Japan
8.1 Japan Persistent Facial Erythema Treatment Market Size (2014-2019)
8.2 Persistent Facial Erythema Treatment Key Players in Japan
8.3 Japan Persistent Facial Erythema Treatment Market Size by Type
8.4 Japan Persistent Facial Erythema Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Persistent Facial Erythema Treatment Market Size (2014-2019)
9.2 Persistent Facial Erythema Treatment Key Players in Southeast Asia
9.3 Southeast Asia Persistent Facial Erythema Treatment Market Size by Type
9.4 Southeast Asia Persistent Facial Erythema Treatment Market Size by Application
10 India
10.1 India Persistent Facial Erythema Treatment Market Size (2014-2019)
10.2 Persistent Facial Erythema Treatment Key Players in India
10.3 India Persistent Facial Erythema Treatment Market Size by Type
10.4 India Persistent Facial Erythema Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Persistent Facial Erythema Treatment Market Size (2014-2019)
11.2 Persistent Facial Erythema Treatment Key Players in Central & South America
11.3 Central & South America Persistent Facial Erythema Treatment Market Size by Type
11.4 Central & South America Persistent Facial Erythema Treatment Market Size by Application
12 International Players Profiles
12.1 Anacor Pharmaceuticals
12.1.1 Anacor Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Persistent Facial Erythema Treatment Introduction
12.1.4 Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.1.5 Anacor Pharmaceuticals Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Persistent Facial Erythema Treatment Introduction
12.2.4 Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.2.5 Astellas Pharma Recent Development
12.3 Galderma
12.3.1 Galderma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Persistent Facial Erythema Treatment Introduction
12.3.4 Galderma Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.3.5 Galderma Recent Development
12.4 Meda Pharmaceuticals
12.4.1 Meda Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Persistent Facial Erythema Treatment Introduction
12.4.4 Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.4.5 Meda Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Persistent Facial Erythema Treatment Introduction
12.5.4 Novartis Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Persistent Facial Erythema Treatment Introduction
12.6.4 Pfizer Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Regeneron Pharmaceuticals
12.7.1 Regeneron Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Persistent Facial Erythema Treatment Introduction
12.7.4 Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.7.5 Regeneron Pharmaceuticals Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Persistent Facial Erythema Treatment Introduction
12.8.4 Sanofi Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.8.5 Sanofi Recent Development
12.9 Valeant Pharmaceuticals
12.9.1 Valeant Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Persistent Facial Erythema Treatment Introduction
12.9.4 Valeant Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)
12.9.5 Valeant Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Persistent Facial Erythema Treatment Key Market Segments
Table Key Players Persistent Facial Erythema Treatment Covered
Table Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Persistent Facial Erythema Treatment Market Size Market Share by Type 2014-2025
Figure Emollients Figures
Table Key Players of Emollients
Figure Antihistamines Figures
Table Key Players of Antihistamines
Figure Antifungal Figures
Table Key Players of Antifungal
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Calcineurin Inhibitors Figures
Table Key Players of Calcineurin Inhibitors
Table Global Persistent Facial Erythema Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Persistent Facial Erythema Treatment Report Years Considered
Table Global Persistent Facial Erythema Treatment Market Size 2014-2025 (Million US$)
Figure Global Persistent Facial Erythema Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Persistent Facial Erythema Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Persistent Facial Erythema Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Persistent Facial Erythema Treatment Market Share by Regions 2014-2019
Figure Global Persistent Facial Erythema Treatment Market Share by Regions 2014-2019
Figure Global Persistent Facial Erythema Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Persistent Facial Erythema Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Persistent Facial Erythema Treatment Market Share by Manufacturers (2014-2019)
Figure Global Persistent Facial Erythema Treatment Market Share by Manufacturers in 2018
Table Global Persistent Facial Erythema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Persistent Facial Erythema Treatment Product/Solution/Service
Table Date of Enter into Persistent Facial Erythema Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Persistent Facial Erythema Treatment Market Size Share by Type (2014-2019)
Figure Global Persistent Facial Erythema Treatment Market Size Market Share by Type (2014-2019)
Table Global Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Persistent Facial Erythema Treatment Market Size Share by Application (2014-2019)
Figure Global Persistent Facial Erythema Treatment Market Size Market Share by Application (2014-2019)
Figure Global Persistent Facial Erythema Treatment Revenue Market Share by Application in 2018
Figure United States Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table United States Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table United States Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure Europe Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table Europe Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table Europe Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure China Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table China Persistent Facial Erythema Treatment Market Size by Type (2014-20189) (Million US$)
Table China Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table China Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table China Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure Japan Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table Japan Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table Japan Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table Southeast Asia Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table Southeast Asia Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure India Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table India Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table India Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table India Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table India Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Figure Central & South America Persistent Facial Erythema Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Persistent Facial Erythema Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Persistent Facial Erythema Treatment Market Share (2018-2019)
Table Central & South America Persistent Facial Erythema Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Persistent Facial Erythema Treatment Market Share by Type (2014-2019)
Table Central & South America Persistent Facial Erythema Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Persistent Facial Erythema Treatment Market Share by Application (2014-2019)
Table Anacor Pharmaceuticals Company Details
Table Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019) (Million US$)
Figure Anacor Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Anacor Pharmaceuticals Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Galderma Company Details
Table Galderma Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Galderma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Galderma Recent Development
Table Meda Pharmaceuticals Company Details
Table Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Meda Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Meda Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Global Persistent Facial Erythema Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Persistent Facial Erythema Treatment Market Size Share by Regions (2019-2025)
Figure Global Persistent Facial Erythema Treatment Market Size Share by Regions in 2025
Figure United States Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Persistent Facial Erythema Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Persistent Facial Erythema Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Persistent Facial Erythema Treatment Market Size by Product (2019-2025)
Figure Global Persistent Facial Erythema Treatment Market Size by Product in 2025
Table Global Persistent Facial Erythema Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Persistent Facial Erythema Treatment Market Size by Application (2019-2025)
Figure Global Persistent Facial Erythema Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
フェイシャルリンクルトリートメントの世界市場：市場規模・現状・予測 Facial wrinkle treatment involves procedures and medication intentional to delay, stop or retard the aging process.The rising geriatric population having age between 35-45 is the primary factor driving the growth of facial wrinkle treatment market. United States is expected to dominate the facial wr…- フェイシャルリンクルトリートメントの世界市場：市場規模・現状・予測 Facial wrinkle treatment involves procedures and medication intentional to delay, stop or retard the aging process.The rising geriatric population having age between 35-45 is the primary factor driving the growth of facial wrinkle treatment market. United States is expected to dominate the facial wr…
- 美容的顔再形成の世界市場：市場規模・現状・予測 Facial Aesthetic Remodeling is a cosmetic procedure entails a comprehensive evaluation of the nature of art, culture or beauty by altering the structure, style or form of something through the treatment of conditions including skin laxity, scars, excess fat, cellulite, wrinkles, moles, skin discolor…
- 先進持続的脅威保護の世界市場：インサイト・予測 Advanced persistent threat are the result of sophisticated adversaries executing a malicious playbook to breach an organization and steal sensitive data. These attacks often occur over an extended time frame, targeting individual users with highly evasive tools, bypassing legacy security approaches …
- 抗真菌治療の世界市場：インサイト・予測 An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.The global Antifungal Trea…